For years, healthcare executives made consequential decisions without one critical input: what the market was actually paying.
Federal price transparency mandates changed that. Negotiated commercial reimbursement rates are now publicly available across payers, service lines, and competitors. The information asymmetry that long shaped healthcare decision-making is beginning to narrow.
But access to data is not the same as using it well.
A divide is emerging between health systems that treat transparency data as a compliance obligation and those that have operationalized it as a strategic intelligence function. The organizations gaining the most ground are no longer walking into negotiations blind. They are building repeatable capabilities that inform contracting, finance, growth planning, and enterprise strategy year-round.
The organizations moving fastest tend to build capabilities across five core areas.
The Five-Phase Framework
Phase 1: Prepare the Data for Decision-Making
Raw machine-readable files (MRFs) are difficult to analyze out of the box. Duplicate records, inconsistent coding structures, missing provider-facility relationships, and unusable negotiated rates can all distort results.
Before analysis can be trusted, the data must be cleaned, normalized, and enriched into a decision-ready format.
Phase 2: Benchmark With Confidence
Once the data is standardized, health systems can begin answering the most important strategic question:
How do our rates compare to the market?
Effective benchmarking compares reimbursement across service lines, payers, and networks using percentage of Medicare as a common metric to enable apples-to-apples comparisons across markets and facility types.
Phase 3: Track the Market Over Time
Payers update their MRFs monthly. Each update becomes another competitive data point.
Health systems that monitor changes continuously enter negotiations with stronger context around pricing movement, competitive positioning, and payer behavior than organizations relying on static snapshots pulled only during renewal cycles.
Phase 4: Expand Beyond Contracting
Transparency data is no longer only a managed care tool.
Strategy, finance, and business development teams increasingly use it to evaluate market expansion opportunities, assess service line economics, inform referral strategy, and analyze acquisition targets.
Phase 5: Build Internal Intelligence Capabilities
The organizations seeing the greatest value from transparency data are embedding it into ongoing operational workflows rather than treating it as a one-time analysis project.
That requires clear ownership across contracting, finance, revenue integrity, and strategy teams—along with access to data that is trustworthy, comparable, and easy to operationalize.
From Framework to Function
The strategic value of price transparency becomes clearest when organizations apply it to real operational decisions.
Example: A Negotiation Gap Hidden Inside the Same Payer Network
Peer benchmarking becomes most valuable when it surfaces meaningful reimbursement differences between comparable systems inside the same payer network.
Within one national PPO network, Texas Health Dallas and UT Southwestern show nearly identical inpatient reimbursement levels for MS-DRGs—both at 496% of Medicare and near the top of the market.
Outpatient reimbursement tells a very different story.
Texas Health Dallas sits at 324% of Medicare for outpatient hospital services, placing it around the 50th percentile in the market. UT Southwestern is reimbursed at 529% of Medicare for the same services—near the 99th percentile—within the same payer network.
.webp)
Inpatient reimbursement is nearly identical across both systems. Outpatient reimbursement is not.
UT Southwestern’s outpatient rates are materially higher within the same payer network—creating a powerful negotiation benchmark for competing systems.
For contracting and finance leaders, this changes the conversation. Rate disparities that were previously invisible can now be quantified, validated, and used as leverage during negotiations.
This kind of peer comparison was not possible before price transparency mandates. Today, it is becoming a routine starting point for sophisticated contracting teams.
Example: Market Entry Analysis in Hours, Not Months
Before transparency data became available, evaluating whether to enter a new market or expand a service line often required months of consultant-driven analysis and heavy reliance on estimates.
Today, health systems can compare markets using observable reimbursement and competitive data before committing significant capital.
Consider a health system evaluating ambulatory surgery center (ASC) expansion across multiple markets.
Using transparency data, strategy teams can evaluate:
- ASC reimbursement rates as a percentage of Medicare
- Commercial lives per existing ASC as a proxy for market capacity
- Hospital outpatient department (HOPD) reimbursement levels as an indicator of payer incentive to shift care settings
- Payer concentration as a measure of negotiating leverage
.webp)
That structured comparison can quickly surface which markets offer the strongest combination of reimbursement opportunity, available demand, payer alignment, and negotiating position.
The inputs are now publicly available.
The competitive advantage comes from knowing how to use them.
The Shift Is Already Underway
Health systems that have operationalized transparency data are already using it to guide contracting, growth, and enterprise strategy decisions.
Many others still struggle to answer foundational questions:
- How do our rates compare by payer and service line?
- Which competitors are gaining pricing advantage?
- Where are payers already granting increases in our market?
- Which markets create the strongest opportunity for expansion?
Getting started does not require building massive internal infrastructure from scratch. It starts with clarity around the decisions that matter most—and access to data that is clean, comparable, and decision-ready.
For a deeper look at each phase, including executive frameworks and real-world case studies, download How Health System Executives Are Using Price Transparency Data to Benchmark, Negotiate, and Grow.